# Semnur Pharmaceuticals, Inc. (SMNR)

> Source: Nexqual · https://nexqual.com/SMNR · data as of 2026-10-15 16:14 UTC · cite as "Nexqual, Semnur Pharmaceuticals, Inc. (SMNR), nexqual.com/SMNR" · informational, not investment advice.

**Price:** USD 0.37 (-29.62% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 0.52 · day 0.37–0.52 · 52w 0.13–23 · market cap $84.3M · PNK

## Key facts
- Total return with dividends: 1Y -95.8% vs S&P 500 +18.1%; 5Y -98.1% vs S&P 500 +85.1%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2025-09-22) |
|---|---|---|
| Total return | -95.8% | -98.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -95.9% | -97.6% |
| Volatility (annualized) | 283.3% | 281.2% |
| Max drawdown | -98.5% (Dec 2025→Jun 2026) | -98.5% (Dec 2025→Jun 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/SMNR · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt